University of California San Francisco
Give to UCSF
Neurologist Bruce Miller Discusses Alzheimer's, FTD on Charlie Rose Show
Neurologist Bruce Miller, MD, director of the UCSF Memory and Aging Center, participated in a roundtable discussion on Alzheimer’s disease and frontotemporal dementia on the "Charlie Rose Show."
Male and Female Behavior Deconstructed
Hormones shape our bodies, make us fertile, excite our most basic urges, and as scientists have known for years, they govern the behaviors that separate men from women. But how?
Saving Dogs with Spinal Cord Injuries
Dogs with spinal cord injuries may soon benefit from an experimental drug being tested by researchers at UCSF and Texas A&M College of Veterinary Medicine & Biomedical Sciences — work that they hope will one day help people with similar injuries.
Three to Receive MLK Award for Exceptional Leadership in Advancing Diversity at UCSF
<p>Three outstanding members of the UCSF community will receive 2012 Dr. Martin Luther King Jr. Awards for their exceptional leadership in advancing the goal of achieving greater ethnic and cultural diversity at UCSF.</p>
Stem Cell and Gene Therapy for Sickle Cell and other Genetic Diseases
<p>A cure for sickle cell anemia and other life-threatening genetic disorders that arise in the blood is the goal of a new $6.7-million, five-year research project headed by UCSF scientist Y. W. Kan, a pioneer of modern genetics and the diagnosis of genetic diseases before birth.</p>
NAS Report Calls for Building Biomedical Knowledge Network to Drive Precision Medicine
<p>A National Academy of Sciences committee co-chaired by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, recommends the creation of a Google maps-like data network that could transform the future of medical discovery, diagnosis and treatment.</p>
First Bay Area Science Festival Draws Thousands
<p>More than 21,000 people converged to AT&T Park for the first annual Bay Area Science Festival, a spectacularly successful community outreach event sponsored in part by UCSF.</p>
New Drug Shows Promise Against Multiple Sclerosis
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
Progress Fighting Malaria: A Timeline
<p>Malaria is an infectious disease caused by a parasite transmitted from person to person by the bite of a mosquito. In the past two centuries, numerous research and public health efforts worldwide have sought to combat this ancient scourge as this timeline shows.</p>
UCSF Cycling Team 'Menstrual Cycles' Fights Multiple Sclerosis
<p><span class="Apple-style-span">With four members diagnosed with multiple sclerosis (MS), three of whom are treated at the nation's leading MS Center at UCSF, a cylcing team will participate in the annual ride through the wine country to raise money to fight MS.</span></p>